References
- Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009;114:501-510. https://doi.org/10.1182/blood-2008-12-195453
- Lee SE, Paik JS, Cho WK, et al. Feasibility of the TNMbased staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Am J Hematol 2011;86:262-266. https://doi.org/10.1002/ajh.21963
- Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS. Central nervous system manifestations of marginal zone B-cell lymphoma. Ann Hematol 2010;89:1003-1009. https://doi.org/10.1007/s00277-010-0976-3
- Cahill MT, Moriarty PA, Kennedy SM. Conjunctival 'MALToma' with systemic recurrence. Arch Ophthalmol 1998;116:97-99. https://doi.org/10.1001/archopht.116.1.97
- Restrepo A, Raez LE, Byrne GE Jr, et al. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma? Crit Rev Oncog 1998;9:269-273.
Cited by
- Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas vol.9, pp.1, 2018, https://doi.org/10.1186/s13550-019-0562-1